| 标题 |
Comparative effectiveness of GLP-1 receptor agonists and SGLT2 inhibitors in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 |
新发表的文章，目前只找到摘要，无全文Introduction: Metabolic dysfunction–associated steatotic liver disease (MASLD) is closely linked to obesity and type 2 diabetes, with incretin-based therapies and SGLT2 inhibitors emerging as promising treatments. However, comparative effectiveness between these pharmacologic classes remains unclear. We performed a systematic review and meta-analysis to compare glucagon-like |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
mmmm
学霸业
忧心的曼凝
无极微光
prigogin
v0id
OK
DW
kaio_escolar
渡人舟
吃葡萄不吐葡萄皮
哇哩哇啦瓦利耶夫娜
初景
jobjobjob
mmyhn
哈哈
Jacky
Nole
Elsevier大王
皖公网安备34019202002308
